Iodide

Iodide

SCHEMBL6136629

CC(C)(C)c1cc(NC(=O)c2cccn2-c2ccc(NCC3=CC=CS3=N)cc2)cc(C(C)(C)C)c1O.I

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
GPX4 P36969 2/20 0.38
SCN3A Q9NY46 2/20 0.35
NR1H4 Q96RI1 4/20 0.33
ALDH1A1 P00352 1/20 0.33
GAA P10253 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
F2 P00734 1/20 0.31
F10 P00742 1/20 0.31
PRSS1 P07477 1/20 0.31
PRSS2 P07478 1/20 0.31
PRSS3 P35030 1/20 0.31
AHSA1 O95433 1/20 0.30
RECQL P46063 1/20 0.30
MAPT P10636 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5852597 0.99 GPX4 (0.38) GPX4SCN3ANR1H4ALDH1A1GAA
SCHEMBL4315656 0.75 GPX4 (0.46) GPX4SCN3ANR1H4ALDH1A1GAA
Iodide SCHEMBL6136762 0.75 SCN10A (0.41) NR1H4ALDH1A1GAATDP1MAPT
SCHEMBL7611372 0.74 SCN10A (0.41) NR1H4ALDH1A1GAATDP1MAPT
Hydrochloric Acid SCHEMBL6136587 0.73 SCN10A (0.41) NR1H4ALDH1A1GAATDP1MAPT
Iodide SCHEMBL4315876 0.73 MEN1 (0.43) GPX4SCN3AALDH1A1GAATDP1
SCHEMBL4311121 0.72 MEN1 (0.44) GPX4SCN3AALDH1A1GAATDP1
SCHEMBL4462886 0.72 MEN1 (0.45) GPX4SCN3ANR1H4ALDH1A1GAA
Iodide SCHEMBL6136663 0.71
SCHEMBL7611004 0.69 MAOB (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991654-B1 NOVEL 2-(IMINOMETHYL)AMINO-PHENYL DERIVATIVES, PREPARATION, APPLICATION AS MEDICINES AND COMPOSITIONS CONTAINING SAME SOD CONSEILS RECH APPLIC (FR) 2005-06-15 EP claimed
US-20020042511-A1 Neuronal Nitric oxide synthase inhibitors; use to treat ischemia SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) 2002-04-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020042511-A1 Neuronal Nitric oxide synthase inhibitors; use to treat ischemia XDH, NOS2, NOS3 GPX4 167/4885SCN3A 468/4885NR1H4 2005/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.